long bone fracture, page-5

pfizer are tied up with athersys. Novartis have stem cell investments through their in house vc. there just the two that i know of.
Didn't know about the mac "scam" so had a look and foudn this, from here:

http://www.biomedreports.com/2011111483534/psti-driven-by-high-volume-manufacturing-capabilities-proprietary-stem-cells-and-new-positive-phase-i-clinical-data-for-pad.html

Both Lonza’s and Pluristem’s facilities will be used to produce commercial quantities of the clinical grade cells for patients in the future. Our queries indicate Pluristem will be able to supply approximately 150,000 doses annually when their new facility is in full production and we assume roughly a similar number of doses will be manufactured when the new Lonza/Mesoblast facility is in full production. The obvious deference is that the Lonza/Mesoblast facility is estimated to cost approximately 33 times more that Pluristem’s facility ($200 million vs. $6.2 million)! This translates into huge differences in the COGS for a cell produced in a Petri dish (the Lonza method) versus cells produced in a 3D method (The Pluristem method)…

Additionally, this doesn’t even address the fact that pluristem has already proven batch-to-batch consistency to the regulators using their 3D manufacturing process while Mesoblast has yet to accomplish this..

Dosn't sound like a scam to me. sounds like maths.
think that's what ive been saying but perhaps a bit cleverer!
Youse blokes keep patting yersleves on the back about how clever you are only listening to one side of the story.